Fierce Pharma

MARCH 14, 2023

Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US kdunleavy Tue, 03/14/2023 - 10:56

101

101

Drug Topics

MARCH 16, 2023

Rates of xylazine use have skyrocketed in since 2010, leading to an increase in overdoses and death.

469

469

IDStewardship

MARCH 12, 2023

In this post a top 10 list of journal articles to read during an infectious diseases pharmacy rotation is provided. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 12 March 2023 As a pharmacist serving as a preceptor to students and residents in the area of infectious diseases since 2010, I have always been on the hunt for good infectious diseases journal articles for my learners to read.

Medication Guidelines 299

Medication Guidelines Documentation Labelling Hospitals 299

PharmaVoice

MARCH 14, 2023

To expand its reach, Christiane Langer, the company’s head of medical affairs, is leaning on connections and singularity over fitting in a box.

246

246

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

MARCH 13, 2023

An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered left shoulder and an allergy to pain medicine. In 16.6 days, it estimated, she would be ready to leave her nursing home. On the 17th day, her Medicare Advantage insurer, Security Health Plan, followed the algorithm and cut off payment for her care, concluding she was ready to return to the apartment where she lived alone.

Nursing Homes 145

Nursing Homes Insurance 145

Drug Topics

MARCH 17, 2023

There was a lower probability of initiating psycholeptics and experiencing postpartum psychiatric emergencies in study patients who continued using antidepressants

468

468

PharmaVoice

MARCH 13, 2023

Babson Diagnostics is trying to create a less invasive blood testing technology — can it gain trust in the post-Theranos era?

162

162

STAT

MARCH 17, 2023

ST. LOUIS — It’s been eight months since Kirsten Bibbins-Domingo, a general internist, cardiovascular researcher, and epidemiologist became the 17th editor in chief of the Journal of the American Medical Association and its network of journals. Bibbins-Domingo, who previously worked at the University of California, San Francisco, was named this week as a member of the 2023 STATUS List of people making a difference in health care and life sciences.

133

133

Drug Topics

MARCH 14, 2023

The product, called Lenire, uses bimodal stimulation and will be available in April 2023

FDA 469

FDA 469

European Pharmaceutical Review

MARCH 14, 2023

Pfizer has announced it will acquire Seagen Inc. for a total enterprise value of $43 billion. “Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining Seagen’s antibody -drug conjugate (ADC) technology… with Pfizer’s capabilities and expertise,” shared Dr Albert Bourla, Pfizer Chairman and Chief Executive Officer.

FDA 119

FDA 119

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

MARCH 13, 2023

Across therapy areas, GoodRx Assist is a proven point-of-sale rebate program for cash-paying patients.

147

147

STAT

MARCH 15, 2023

In the summer and fall of 2021, West Nile virus spread rapidly through Arizona’s Maricopa County and other areas of the state. The outbreak, with more than 1,700 cases reported and 127 deaths. was the largest in the United States since the mosquito-borne virus first emerged in this country in 1999. But with the nation facing a far larger public health crisis with the Covid-19 pandemic, it went almost unnoticed.

126

126

Drug Topics

MARCH 14, 2023

According to a company press release, the price reductions will go into effect at the start of 2024

469

469

Fierce Healthcare

MARCH 17, 2023

#FierceMadness: The competition to determine healthcare's most powerful person is back!

118

118

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

MARCH 17, 2023

Dr. Ryan Saadi, CEO of Tevogen Bio, is making good on a lifelong goal of bringing T cell therapies to people who need them.

130

130

European Pharmaceutical Review

MARCH 17, 2023

In a first-of-its-kind commercial agreement, Great Ormond Street Hospital NHS Foundation Trust (GOSH) will work with Leucid Bio to manufacture LEU011, a lateral Chimeric Antigen Receptor (CAR) targeting NKG2D ligands. The CAR T therapy will be used in clinical studies for solid tumours and haematological malignancies. Under the agreement the parties will work together at state-of-the-art cleanroom facilities at the Zayed Centre for Research into Rare Disease in Children.

Immunization 115

Immunization Hospitals 115

Drug Topics

MARCH 14, 2023

Per VA regulations, anyone who has had a stroke or seizure within the last year, as well as those with MRIs showing microhemmorrhages, aneurysms, lesions or tumors would be excluded from coverage of the drug, called Leqambi

469

469

Fierce Healthcare

MARCH 16, 2023

Pennsylvania systems Penn Medicine, Crozer Health cut jobs amid reorganizations dmuoio Thu, 03/16/2023 - 16:19

118

118

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

MARCH 16, 2023

The recent departure of neurodegenerative development head Samantha Budd Haeberlein is just the latest sign of a changing tide among Biogen’s post-Aduhelm leadership.

130

130

Pharmaceutical Technology

MARCH 14, 2023

The National Health Surveillance Agency (ANVISA) in Brazil has granted approval for Takeda ’s dengue virus vaccine candidate, Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003). The vaccine has received approval for preventing dengue disease in people aged four years to 60 years. Qdenga has been developed based on a live-attenuated dengue serotype 2 virus that offers the genetic backbone for four dengue virus serotypes and is designed to provide protection against any of these.

Vaccines 114

Vaccines Immunization 114

Drug Topics

MARCH 14, 2023

How are hiring trends shaping up for the future of health care?

469

469

Fierce Healthcare

MARCH 17, 2023

The ACA slimmed coverage gaps between racial and ethnic groups: study pminemyer Fri, 03/17/2023 - 16:21

115

115

PharmaVoice

MARCH 16, 2023

A $43 billion deal that doubles the pharma giant's cancer pipeline shows that M&A is back on the table in pharma.

130

130

STAT

MARCH 17, 2023

Around 4:30 p.m. last Friday, Ketamine Wellness Centers CEO Kevin Nicholson sent an email: In 30 minutes, the company would no longer be in business, he said. The message went out to some patients and to all of the employees of his company’s clinics across nine states — what had, up until moments before, been one of the largest ketamine clinic chains in the country.

113

113

Drug Topics

MARCH 17, 2023

Polio prevalence has been reduced by 99.99% in the past 35 years. But the disease continues to exist in countries like Pakistan and Afghanistan, where it seeds outbreaks elsewhere.

247

247

Fierce Healthcare

MARCH 16, 2023

HHS $25M grant program would expand mental health care services in schools fdiamond Thu, 03/16/2023 - 16:23

115

115

PharmaVoice

MARCH 15, 2023

What we’re looking for in each new class of honorees.

130

130

Pharmaceutical Technology

MARCH 17, 2023

As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway for patients and on the market. At the same time, experts are saying developers in the field need to double down on securing clinical data to allow for its continued maturation. Companies are testing the use of digital platforms along with pharmacological treatments.

Packaging 111

Packaging Patient Care FDA 111

Drug Topics

MARCH 17, 2023

Your weekly roundup of the latest news from Drug Topics®.

247

247

Fierce Healthcare

MARCH 15, 2023

Biden's 'Cancer Moonshot' is already being fueled by tech addressing breast cancer aburky Wed, 03/15/2023 - 12:05

115

115

PharmaVoice

MARCH 15, 2023

Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. When Novartis acquired AveXis and its spinal muscular atroph.

130

130

STAT

MARCH 17, 2023

Moderna CEO Stéphane Bancel is starting to reap gargantuan gains from the stock he first got when he started with the company a decade ago, although nearly all of this chunk of his fortune remains earmarked for unknown charities. Bancel made $398 million in 2022 based on the actual realized gains of stock that was exercised and sold, according to STAT’s calculations from Moderna’s annual compensation disclosure filed this week.

Vaccines 111

Vaccines 111

Drug Topics

MARCH 17, 2023

The vaccine, developed by GSK, is "very encouraging" step in fight to treat meningococcal disease

Vaccines 247

Vaccines 247